Health Canada has issued a Qualifying Notice for the approval of dronabinol/cannabidiol

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1594, 2007-01, pp. : 23-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Canadians' WTP for dronabinol/cannabidiol analysed

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 574, 2009-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Health Canada has issued a reminder to consumers advising against the use of products containing aristolochic acid.

Reactions Weekly, Vol. 1, Iss. 1042, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Health Canada has issued a `Dear Pharmacist' letter advising of a recall of certain sustained-release potassium replacement products

Reactions Weekly, Vol. 1, Iss. 1018, 2004-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

GlaxoSmithKline (GSK), in consultation with Health Canada, has issued a precautionary recall of one lot of Infanrix Hexa

Reactions Weekly, Vol. 1, Iss. 1428, 2012-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Health Canada's Therapeutic Products Directorate has granted manufacturing and marketing approval for tamsulosin 0.4mg capsules [Ranbaxy Laboratories].

Inpharma, Vol. 1, Iss. 1616, 2007-01 ,pp. : 27-27

Adis International

Access to resources Recommend Favorite